- If you are wondering whether ADMA Biologics is attractively priced at its current level, this article walks through the numbers so you can judge the valuation with more confidence.
- The stock last closed at US$15.99, with returns of a 1.8% decline over 7 days, a 7.6% decline over 30 days, a 10.6% decline year to date, a 0.5% decline over 1 year, a very large gain over 3 years and a very large gain over 5 years.
- These mixed shorter term and very strong multi year returns have kept ADMA Biologics on many investors’ watchlists, as past price moves often influence how people think about current risk and reward. In the sections that follow, we will set those moves aside and focus on what the current share price implies about the business…
Is ADMA Biologics (ADMA) Pricing Reflecting Its Multi Year Share Price Surge?
Share this article
More News
Ripple CLO urges Senate to hear crypto holders
September 9, 2026
XE Stock Slides As Price Action Diverges From Strong Cash Position
September 9, 2026
The resurgence of crypto in the ETF market
September 9, 2026
